Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that our Registrar and Transfer Agent viz. Link Intime Indian Private Limited informed us on March 16, 2024 regarding the loss of the share certificates and request for the issue of duplicate share certificates from the shareholder.
18-03-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Restructuring

 The Board of Directors of the Company has approved an internal restruturing of foreign subsidiaries of the Company.
16-02-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Restructuring

 The Board of Directors of the Company has approved an internal restruturing of foreign subsidiaries of the Company.
16-02-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited has informed us regarding the loss of share certifcate and request for the issue of duplicate share certificate from the share certificate from the shareholder.
06-02-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited has informed us on January 24, 2024 regarding the loss of share certificate and request for the issue of duplicate share certificate from the shareholder.
25-01-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of newspaper advertisement published regarding extract of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023, ''The Economic Times & The Free Press Journal'' an English Daily and ''Maharashtra Times & Navshakti'' a Regional Daily, on January 25, 2024.
25-01-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023

 Enclosed herewith the outcome of board meeting held on January 23, 2024
23-01-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons of the Company and their immediate relatives of the Company from January 01, 2024, and shall remain closed until 48 hours after the announcement of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023.
16-01-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that our Registrar and Transfer Agent viz. Link Intime India Private Limited has informed us regarding the loss of share certificate and request for the issue of duplicate share certificate from the shareholder.
16-01-2024
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on November 10, 2023, has approved the allotment of 18,000 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited -Employee Stock Option Plan 2019.
12-01-2024
Next Page
Close

Let's Open Free Demat Account